MedTrace Logo

Myeloma Novel Drug Discovery Ver 1.2

NCT05968417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-08-03

No results posted yet for this study

Summary

Myeloma is a bone marrow cancer with over 5000 patients diagnosed in the UK each year. Researchers are committed to improving understanding of myeloma and developing more effective treatments with fewer side effects in order to improve patient outcomes. In order to do this, researchers are collecting samples of blood and bone marrow to test the activity of potential new treatments in the laboratory and to understand what may be the cause of some treatments not working.

Conditions

Interventions

OTHER

Observational study - sample collection only.

No intervention - blood and/or bone marrow sample collection only

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    collaborator OTHER

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2033-02-28
Completion
2035-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05968417 on ClinicalTrials.gov